181 related articles for article (PubMed ID: 35565268)
21. ErbB-3 predicts survival in ovarian cancer.
Tanner B; Hasenclever D; Stern K; Schormann W; Bezler M; Hermes M; Brulport M; Bauer A; Schiffer IB; Gebhard S; Schmidt M; Steiner E; Sehouli J; Edelmann J; Läuter J; Lessig R; Krishnamurthi K; Ullrich A; Hengstler JG
J Clin Oncol; 2006 Sep; 24(26):4317-23. PubMed ID: 16896008
[TBL] [Abstract][Full Text] [Related]
22. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of HER2/HER3 and clinical feature of ovarian cancer.
Chung YW; Kim S; Hong JH; Lee JK; Lee NW; Lee YS; Song JY
J Gynecol Oncol; 2019 Sep; 30(5):e75. PubMed ID: 31328457
[TBL] [Abstract][Full Text] [Related]
24. High expression of HER3 is associated with a decreased survival in gastric cancer.
Hayashi M; Inokuchi M; Takagi Y; Yamada H; Kojima K; Kumagai J; Kawano T; Sugihara K
Clin Cancer Res; 2008 Dec; 14(23):7843-9. PubMed ID: 19047113
[TBL] [Abstract][Full Text] [Related]
25. [Clinicopathological features and prognosis of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer].
Wang Y; Zhang S; Zhang H; Liang L; Xu L; Cheng YJ; Duan XN; Liu YH; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):853-862. PubMed ID: 36241228
[TBL] [Abstract][Full Text] [Related]
26. Wnt7a Deficiency Could Predict Worse Disease-Free and Overall Survival in Estrogen Receptor-Positive Breast Cancer.
Yi K; Min KW; Wi YC; Kim Y; Shin SJ; Chung MS; Jang K; Paik SS
J Breast Cancer; 2017 Dec; 20(4):361-367. PubMed ID: 29285041
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of the primary tumor site and immune indexes in patients with estrogen receptor-positive, human epidermal growth factor receptor-2-negative breast cancer.
Song X; Ma J; Zhang H; Zhang Q
Gland Surg; 2020 Oct; 9(5):1450-1468. PubMed ID: 33224820
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast.
Mitra D; Bhattacharyya S; Alam N; Sen S; Mitra S; Mandal S; Vignesh S; Majumder B; Murmu N
Breast Cancer Res Treat; 2020 Jan; 179(2):359-370. PubMed ID: 31686261
[TBL] [Abstract][Full Text] [Related]
29. Progression of Precancerous Cervical Lesion Predicted by p16 Protein Immunohistochemistry in Rajavithi Hospital.
Charoonwatana T; Boonlikit S; Yanaranop M
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1809-1815. PubMed ID: 31244304
[TBL] [Abstract][Full Text] [Related]
30. Open versus minimally invasive radical hysterectomy for early cervical cancer: A two-center retrospective cohort study with pathologic review of usual-type adenocarcinoma and adenosquamous carcinoma.
Kim Y; Kim SI; Kim H; Lee M; Kim HS; Kim K; Chung HH; No JH; Kim YB; Kim JW; Park NH; Song YS; Lee C; Suh DH
Gynecol Oncol; 2022 Oct; 167(1):28-36. PubMed ID: 35970602
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer.
Luhtala S; Staff S; Kallioniemi A; Tanner M; Isola J
BMC Cancer; 2018 Oct; 18(1):1045. PubMed ID: 30367623
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma.
Huang C; Huang Z; Zhao X; Wang Y; Zhao H; Zhong Z; Wang L
Onco Targets Ther; 2018; 11():2111-2120. PubMed ID: 29695918
[TBL] [Abstract][Full Text] [Related]
33. Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix.
Lee CM; Shrieve DC; Zempolich KA; Lee RJ; Hammond E; Handrahan DL; Gaffney DK
Gynecol Oncol; 2005 Nov; 99(2):415-21. PubMed ID: 16157365
[TBL] [Abstract][Full Text] [Related]
34. In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer.
Spears M; Taylor KJ; Munro AF; Cunningham CA; Mallon EA; Twelves CJ; Cameron DA; Thomas J; Bartlett JM
Breast Cancer Res Treat; 2012 Apr; 132(2):463-70. PubMed ID: 21638049
[TBL] [Abstract][Full Text] [Related]
35. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
36. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
[TBL] [Abstract][Full Text] [Related]
37. Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis.
Keren S; Shoude Z; Lu Z; Beibei Y
Tumour Biol; 2014 Mar; 35(3):2285-95. PubMed ID: 24234257
[TBL] [Abstract][Full Text] [Related]
38. Expression and clinicopathological significance of hematopoietic pre-B cell leukemia transcription factor-interacting protein in cervical carcinoma.
Wang Y; Li D; Liu Y; Tian S; Chen X
Pathol Res Pract; 2018 Sep; 214(9):1340-1344. PubMed ID: 30033330
[TBL] [Abstract][Full Text] [Related]
39. Neuregulin expression in solid tumors: prognostic value and predictive role to anti-HER3 therapies.
Ocaña A; Díez-González L; Esparís-Ogando A; Montero JC; Amir E; Pandiella A
Oncotarget; 2016 Jul; 7(29):45042-45051. PubMed ID: 27074567
[TBL] [Abstract][Full Text] [Related]
40. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
